--2026/FY-- / 420.495M--
--2025/FY-- / 145.456M--
--------
--------
--------
Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Charter Communications
CHTR
5
MasterCard
MA
HK Stock MarketDetailed Quotes
02561 VISEN PHARMA-B
- 44.200
- -0.950-2.10%
Not Open May 6 16:08 CST
5.04BMarket Cap-25.59P/E (TTM)
45.150High44.200Low17.10KVolume45.150Open45.150Pre Close759.76KTurnover0.02%Turnover RatioLossP/E (Static)113.93MShares69.15052wk High19.33P/B5.04BFloat Cap39.25052wk Low--Dividend TTM113.93MShs Float69.150Historical High--Dividend LFY2.10%Amplitude39.250Historical Low44.430Avg Price100Lot Size--Div YieldTTM--Div Yield LFY
VISEN PHARMA-B Key Stats
VISEN PHARMA-B Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency:
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
VISEN PHARMA-B Earnings Reports
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting